BioVenic expands its integrated Animal Omics Solutions to support high-resolution, multi-layer animal research.
See how Bambanker™ supports high post-thaw recovery and reliable downstream performance across tissues, organoids, tumor ...
Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...
This Clinical Chemistry and Laboratory Medicine review examines a central challenge in precision medicine: whether medical ...
Uveitis, which accounts for 10%–15% of blindness cases in developed nations and 25% in developing regions, represents a ...
"RNA modifications are central to how cells respond to their environment," said Gudrun Stengel, Ph.D., Chief Executive Officer of Alida Biosciences. "With EpiPlex Tri-Mod, we move beyond method ...
Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...
The development of tendon tissue engineering and regenerative medicine depends heavily on whether in vitro mechanical stimulation can faithfully ...
A research paper by scientists at University of Oxford presented a humanoid robotic bioreactor capable of delivering ...
BostonGene, a developer of the leading AI foundation model for tumor and immune biology, today announced that 13 abstracts have been selected for presentation at the American Association for Cancer ...
Unbiased DIA mass spectrometry quantified 5702 proteins, identifying 468 upregulated and 1296 downregulated proteins in MCL versus normal B cells, including strong CCND1 overabundance. Coordinated ...
Multicenter prospective validation of PanClaudinAI: An AI for predicting Claudin 18.2 from CT in pancreatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results